MorphoSys AG - ADR Financials

$18.96

$-- (--%)

As on 09-Aug-2024 09:30EDT

Market cap

$2,856 Mln

Revenue (TTM)

$204 Mln

P/E Ratio

--

P/B Ratio

53.8

Div. Yield

0 %

Annual
Quarterly

Income Statement (€ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	203.58	238.28	278.27	179.60	327.70	71.76
Cost of Revenue	41.22	58.36	48.62	32.20	9.17	12.09
Gross Profit	162.36	179.92	229.65	147.40	318.52	59.67
Operating Expenses	607.98	430.78	450.36	425.00	300.57	167.77
Operating Profit (EBIT)	-447.34	-252.48	162.26	-277.60	119.41	-105.12
Other Income	--	--	--	--	--	--
Profit before Tax	-455.94	-190.92	17.52	-591.10	22.49	-106.52
Provision for Tax	27.43	-1.19	168.58	-76.60	-75.40	-3.51
Profit after Tax (Net Income)	-460.26	-189.73	-151.06	-514.50	97.89	-103.01
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-193.57	--	-151.06	-514.46	97.89	-103.01

Liabilities (€ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	-261.67	49.05	157.41	244.88	621.32	394.70
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	1,605.36	1,712.95	1,961.18	2,026.84	837.73	40.18
Current Liabilities	487.84	264.31	278.35	284.54	200.46	61.56
Total Liabilities	2,319.37	2,026.31	2,396.93	2,556.25	1,659.51	496.44

Assets (€ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	1,156.52	1,212.29	1,307.89	1,423.28	452.70	192.75
Current Assets	675.01	814.02	1,089.04	1,132.97	1,206.82	303.69
Total Assets	2,506.54	2,026.31	2,396.93	2,556.25	1,659.51	496.44
Total Debt*	261.04	635.93	339.46	325.79	318.20	42.57
Net Current Assets	--	549.71	810.69	848.43	1,006.36	242.13

Cashflow (€ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	-295.84	-366.71	-481.45	35.27	-80.14
Cash Flow from Investing Activities	--	15.37	345.00	-831.01	-879.62	78.55
Cash from Financing Activities	--	43.00	311.42	1,322.92	907.19	0.35
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS (€)	-3.20	-1.20	-1.11	-3.77	0.75	-0.81
Cash EPS (€)	--	-1.13	-1.03	-3.69	0.81	-0.76
Adjusted Book Value (€)	--	0.31	1.15	1.79	4.74	3.11
Dividend per Share (€)	--	--	--	--	--	--
Cash Flow per Share (€)	--	-1.87	-2.68	-3.53	0.27	-0.63
Free Cash Flow per Share (€)	--	-1.89	-2.79	-3.72	-0.11	-0.66

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	-32.11	-28.30	-68.14	14.22	-21.38
ROE (%)	--	-183.80	-75.10	-118.80	19.27	-23.33
ROA (%)	-18.41	-8.58	-6.10	-24.41	9.08	-19.90
EBIT Margin (%)	-165.32	-46.98	58.36	-105.40	36.44	-146.52
Net Margin (%)	-226.08	-79.63	-54.29	-286.47	29.87	-143.56
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	-31.94	-0.14	0.55	-0.45	3.57	-0.06
EBIT Growth (%)	-268.32	-168.94	185.79	-258.51	213.59	-79.15
Net Profit Growth (%)	-536.29	-25.60	70.64	-625.59	195.03	-83.39
EPS Growth (%)	-504.26	-0.08	0.71	-6.04	1.92	-0.83
Book Value Growth (%)	-344.94	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	--	12.97	2.16	1.33	0.51	0.11
Short term debt to equity ratio	-0.02	0.29	0.06	0.01	0.01	0.01
Current Ratio	1.38	3.08	3.91	3.98	6.02	4.93
Quick Ratio	1.38	2.84	3.83	3.91	5.97	4.93
Interest Coverage	-3.26	-1.02	1.39	-1.04	1.24	-46.27

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	15.14	17.90	40.38	47.77	27.41	28.35
Asset Turnover	0.08	0.11	0.11	0.09	0.30	0.14
Receivable days	--	118.80	130.04	178.58	61.40	97.69
Inventory Days	--	270.15	169.06	174.22	204.06	8.06
Payable days	--	209.58	422.07	688.22	1,158.84	270.04
Cash Conversion Cycle	--	179.37	-122.97	-335.42	-893.38	-164.29

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.